• AMERICAN ORIENTAL BIOENGR IN Financial Overview

  • Income Statement: AOB

      2006 2005 Change ( 2005 - 2006  )
    Net Sales/Revenues 110.18 M 54.73 M 55.45 M 50.33%
    Gross Profit 68.51 M 32.20 M 36.30 M 52.99%
    Net Income Before Extra Items/Preferred Div 29.20 M 13.43 M 15.77 M 54.02%
    Operating Income 36.38 M 18.34 M 18.04 M 49.58%
  • Cash Flow: AOB

      2006 2005 Change ( 2005 - 2006  )
    Net Cash Flow - Financing 26.16 M 39.66 M -13.51 M -51.63%
    Net Cash Flow - Investing 26.39 M 5.86 M 20.52 M 77.78%
    Net Cash Flow/Operating Activities 29.09 M 11.40 M 17.69 M 60.81%
  • Balance Sheet: AOB

      2006 2005 Change ( 2005 - 2006  )
    Total Assets 183.48 M 98.81 M 84.67 M 46.15%
    Total Liabilities 27.30 M 8.06 M 19.24 M 70.47%
    Shareholders Equity 156.18 M 90.75 M 65.43 M 41.90%
  • Key Ratios / Statistics: AOB

    • Valuation

      Price/Earnings (TTM) 25.37
      Price/Sales (TTM) 6.66
      Price/Book (MRQ) 3.09
      Price/Cash Flow (TTM)
    • Profitability

      Gross Margin 62.17
      Operating Margin 33.02
      Profit Margin 26.50
    • Dividends

      Dividend Paid (TTM)
      Payout Ratio % (TTM)
    • Financial Strength

      Quick Ratio (MRQ) 4.40
      Current Ratio (MRQ) 5.94
      Long Term Debt-to-Equity (MRQ) 1.06
    • Management Effectiveness

      Return on Equity (TTM) 23.02
      Return on Assets (TTM) 18.80
      Return on Investments (TTM) 22.32